mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-07 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |